Petros Pharmaceuticals Stock Forecast - Day Typical Price
| PTPI Stock | USD 0.27 0.02 6.90% |
Petros Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Petros Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Petros |
| Previous Day Typical Price | Day Typical Price | Trend |
| 0.25 | 0.27 |
| Check Petros Pharmaceuticals Volatility | Backtest Petros Pharmaceuticals | Trend Details |
Petros Pharmaceuticals Trading Date Momentum
| On November 25 2024 Petros Pharmaceuticals was traded for 0.29 at the closing time. The top price for the day was 0.29 and the lowest listed price was 0.25 . The trading volume for the day was 348 K. The trading history from November 25, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 7.41% . The trading delta at closing time against the current closing price is 3.70% . |
The period considered in calculating typical price is a single trading day, however the typical price can also be applied to other time spans such as a week, month or year.
| Compare Petros Pharmaceuticals to competition |
Other Forecasting Options for Petros Pharmaceuticals
For every potential investor in Petros, whether a beginner or expert, Petros Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Petros Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Petros. Basic forecasting techniques help filter out the noise by identifying Petros Pharmaceuticals' price trends.Petros Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Petros Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Petros Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Petros Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Petros Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Petros Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Petros Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Petros Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Petros Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Petros Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Petros Pharmaceuticals stock market strength indicators, traders can identify Petros Pharmaceuticals entry and exit signals to maximize returns.
Petros Pharmaceuticals Risk Indicators
The analysis of Petros Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Petros Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting petros stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.98 | |||
| Standard Deviation | 6.18 | |||
| Variance | 38.19 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Petros Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Petros Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Petros Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Petros Pharmaceuticals Stock:Check out Historical Fundamental Analysis of Petros Pharmaceuticals to cross-verify your projections. For more detail on how to invest in Petros Stock please use our How to Invest in Petros Pharmaceuticals guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Petros Pharmaceuticals. If investors know Petros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Petros Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.80) | Revenue Per Share 0.99 | Quarterly Revenue Growth (0.29) | Return On Assets (0.31) | Return On Equity (0.64) |
The market value of Petros Pharmaceuticals is measured differently than its book value, which is the value of Petros that is recorded on the company's balance sheet. Investors also form their own opinion of Petros Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Petros Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Petros Pharmaceuticals' market value can be influenced by many factors that don't directly affect Petros Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Petros Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Petros Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Petros Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.